ATYR
aTyr Pharma Inc
$0.31
0.01 (3.26%) Today
— up— down
Market Cap
$30M-61.3%
Revenue (TTM)
$186.29K-19.1%
Net Income (TTM)
$-78,067,410
$-78,067,410EPS (TTM)
-0.80
-0.80Shares Out
98.05M
98.05MOpen
$0.31
$0.31Previous Close
$0.30
$0.30Day Range
$0.27 – $0.32
$0.27 – $0.3252-Week Range
$0.27 – $1.12
$0.27 – $1.12Beta
0.97
0.97Volume
3.83M
3.83MAvg Volume
3.12M
3.12MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout ATYR
aTyr Pharma is a public biotherapeutics company that is focused on researching the extracellular functionality and signaling pathways of tRNA synthetases.
Related
News
N/AN/AN/AN/A
Positive FDA Alignment Boosts ATyr Pharma's Rare Lung Disease
Yahoo · 5d ago
aTyr Pharma FDA Alignment Sets Protocol for Phase 3 Efzofitimod Study in Pulmonary Sarcoidosis
Yahoo · 5d ago
aTyr Pharma Announces Alignment with FDA on Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis
Yahoo · 5d ago
aTyr Pharma Reaches FDA Alignment On Protocol For A Phase 3 Study Of Its Lead Therapeutic Candidate Efzofitimod In Patients With Chronic, Symptomatic Pulmonary Sarcoidosis With Restrictive Lung Disease; Expects To Initiate Study-Related Activities In Q4 2026
Benzinga · 5d ago